A federal law that is fiercely opposed by the testing industry would give manufacturers of medical tests that have long eluded government control approximately four years to demonstrate that their new products yield correct results.
The Food and Drug Administration adopted a regulation on Monday that will phase in control of new tests created by laboratories, a multibillion-dollar business that authorities claim is posing increasing hazards to Americans. The aim is to guarantee the safety, accuracy, and dependability of new tests for a wide range of ailments, including genetic disorders, heart disease, cancer, and Covid.
According to a release from FDA commissioner Robert Califf, “the final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust.”
According to Califf, improper testing can result in waiting longer to receive the right therapy or in needless treatment.
However, the FDA made the important decision to waive the federal review requirement for the tens of thousands of tests that are now available on the market. The government stated that in order to allay worries that the new regulation “may lead to the widespread loss of access to beneficial” testing, it will effectively grandfather certain tests into approval.